NLS Other Non Cash Items from 2010 to 2024

NLSPW Stock  USD 0.01  0  15.56%   
NLS Pharmaceutics Other Non Cash Items yearly trend continues to be fairly stable with very little volatility. Other Non Cash Items is likely to outpace its year average in 2024. During the period from 2010 to 2024, NLS Pharmaceutics Other Non Cash Items regression line of quarterly data had r-squared of  0.04 and coefficient of variation of (459.04). View All Fundamentals
 
Other Non Cash Items  
First Reported
2010-12-31
Previous Quarter
59.5 K
Current Value
62.5 K
Quarterly Volatility
18.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NLS Pharmaceutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NLS Pharmaceutics' main balance sheet or income statement drivers, such as Interest Income of 681.3 K, Depreciation And Amortization of 9.8 K or Interest Expense of 137.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NLS financial statements analysis is a perfect complement when working with NLS Pharmaceutics Valuation or Volatility modules.
  
Check out the analysis of NLS Pharmaceutics Correlation against competitors.

Latest NLS Pharmaceutics' Other Non Cash Items Growth Pattern

Below is the plot of the Other Non Cash Items of NLS Pharmaceutics AG over the last few years. It is NLS Pharmaceutics' Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NLS Pharmaceutics' overall financial position and show how it may be relating to other accounts over time.
Other Non Cash Items10 Years Trend
Pretty Stable
   Other Non Cash Items   
       Timeline  

NLS Other Non Cash Items Regression Statistics

Arithmetic Mean(4,100,375)
Coefficient Of Variation(459.04)
Mean Deviation9,069,293
Median884,309
Standard Deviation18,822,257
Sample Variance354.3T
Range73.9M
R-Value(0.20)
Mean Square Error366.5T
R-Squared0.04
Significance0.48
Slope(835,034)
Total Sum of Squares4959.9T

NLS Other Non Cash Items History

202462.5 K
202359.5 K
2022364.6 K
2021166.5 K
2020-72.1 M
20191.1 M
20181.7 M

About NLS Pharmaceutics Financial Statements

NLS Pharmaceutics investors use historical fundamental indicators, such as NLS Pharmaceutics' Other Non Cash Items, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NLS Pharmaceutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Non Cash Items59.5 K62.5 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NLS Stock Analysis

When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.